Comparison of Transplacental Treatment of Fetal Supraventricular Tachyarrhythmias With Digoxin, Flecainide, and Sotalol
Authors:
- 18 October 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 124 (16) , 1747-1754
Abstract
Background—: Fetal tachyarrhythmia may result in low cardiac output and death. Consequently, antiarrhythmic treatment is offered in most affected pregnancies. We compared 3 drugs commonly used to control supraventricular tachycardia (SVT) and atrial flutter (AF). Methods and Results—: We reviewed 159 consecutive referrals with fetal SVT (n=114) and AF (n=45). Of these, 75 fetuses with SVT and 36 with AF were treated nonrandomly with transplacental flecainide (n=35), sotalol (n=52), or digoxin (n=24) as a first-line agent. Prenatal treatment failure was associated with an incessant versus intermittent arrhythmia pattern (n=85; hazard ratio [HR]=3.1; P P =0.04). Atrial flutter had a lower rate of conversion to sinus rhythm before delivery than SVT (HR=2.0; P =0.005). Cardioversion at 5 and 10 days occurred in 50% and 63% of treated SVT cases, respectively, but in only 25% and 41% of treated AF cases. Sotalol was associated with higher rates of prenatal AF termination than digoxin (HR=5.4; P =0.05) or flecainide (HR=7.4; P =0.03). If incessant AF/SVT persisted to day 5 (n=45), median ventricular rates declined more with flecainide (−22%) and digoxin (−13%) than with sotalol (−5%; P P =0.02) and digoxin (HR=2.9; P =0.01) were also associated with a higher rate of conversion of fetal SVT to a normal rhythm over time. No serious drug-related adverse events were observed, but arrhythmia-related mortality was 5%. Conclusion—: Flecainide and digoxin were superior to sotalol in converting SVT to a normal rhythm and in slowing both AF and SVT to better-tolerated ventricular rates and therefore might be considered first to treat significant fetal tachyarrhythmia.Keywords
This publication has 24 references indexed in Scilit:
- Evaluation of fetal arrhythmias from simultaneous pulsed wave Doppler in pulmonary artery and veinHeart, 2006
- Amiodarone Therapy for Drug-Refractory Fetal TachycardiaCirculation, 2004
- Management of fetal tachyarrhythmia based on superior vena cava/aorta Doppler flow recordingsHeart, 2003
- Fetal supraventricular tachycardia: a role for amiodarone as second‐line therapy?Prenatal Diagnosis, 2003
- The efficacy of flecainide versus digoxin in the management of fetal supraventricular tachycardiaPrenatal Diagnosis, 1995
- Management outcome and follow-up of fetal tachycardiaJACC, 1994
- Fetal Response Time to Transplacental Digoxin Therapy for Supraventricular Tachyarrhythmia: A Meta-AnalysisThe Journal of Maternal-Fetal & Neonatal Medicine, 1993
- Fetal tachyarrhythmias: transplacental and direct treatment of the fetus—a report of 60 casesUltrasound in Obstetrics & Gynecology, 1991
- Flecainide in the treatment of fetal tachycardias.Heart, 1991
- Treatment of fetal supraventricular tachyarrhythmiasJournal of Clinical Ultrasound, 1985